Stay updated on Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial page.

Latest updates to the Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial page
- Check6 days agoChange DetectedThe page header now shows Revision: v3.3.2, replacing the previous Revision: v3.3.1. This is a metadata update that does not affect study content or user-facing details.SummaryDifference0.0%

- Check13 days agoChange Detected- The page shows a system revision from v3.2.0 to v3.3.1 with no user-visible changes to study content or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedRemoved the generic government funding status notice from the page. The study details, locations, and eligibility criteria remain unchanged.SummaryDifference0.2%

- Check34 days agoChange DetectedResults have been posted (Results First Posted 2025-04-24) and the study is reported as terminated early due to not meeting primary and key secondary endpoints, with safety outcomes summarized.SummaryDifference0.3%

- Check63 days agoChange DetectedMajor update: adds a government funding and operating status notice and marks the page as revision v3.2.0, replacing v3.1.0.SummaryDifference2%

- Check70 days agoChange DetectedAdded a new revision label v3.1.0 and removed several drug-safety and pharmaceutical topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision v3.0.2. The update shifts the page toward a release/versioning focus while narrowing drug-related content.SummaryDifference0.3%

Stay in the know with updates to Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegcetacoplan in ALS Adults: Efficacy & Safety Clinical Trial page.